CRISPR Therapeutics AG Market Capitalization: Historic Market Cap and Yearly Evolution

                        
Market Cap
CRISPR Therapeutics AG Market Capitalization:
                            $4.70 Billion
                            
                            USD as of April 1, 2022
                            
                        business
                        
                            CRISPR Therapeutics AG Company Profile
                        
                                    CRISPR Therapeutics AG Main Stock Listing
                                
                                show_chart
                                NASDAQ: CRSP

Market Capitalization History of CRISPR Therapeutics AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of CRISPR Therapeutics AG market cap

Date	Market Cap	YoY Change
Jan. 1, 2022	$5.66 B	-49.99%
Jan. 1, 2021	$11.32 B	151.39%
Jan. 1, 2020	$4.50 B	113.18%
Jan. 1, 2019	$2.11 B	21.68%
Jan. 1, 2018	$1.74 B	15.89%
Jan. 1, 2017	$1.50 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Best-Selling Downloads

$29.90

$99.90

580 Unicorn Startup Companies – Excel Spreadsheet

$29.90

$24.90

Top 1300 UK Companies [FTSE All-Share + FTSE AIM All-Share] – Excel Download

$59.90

$19.90

Save tens of hours in 2 minutes!

CRISPR Therapeutics AG Categories

Switzerland Healthcare Biotechnology

Switzerland Healthcare

Switzerland Biotechnology

Stocks & Indices

CRISPR Therapeutics AG has the following listings and related stock indices.

Stock: NASDAQ: CRSP

NASDAQ Composite

Stock: BMV: CRSPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.